Table 2: Comparison of Laboratory findings between the
intervention (convalescent plasma) group and the control (dexamethasone) group
at baseline.
Hematological parameters,
value (95% CI) |
Control group (N = 50) |
Convalescent plasma (N = 28) |
p-value |
||
Haemoglobin, mmol/L |
7.7 |
(7.1 – 8.4) |
7.3 |
(6.7 – 8.1) |
.26 |
Hematocrit, % |
37 |
(34 – 40) |
36 |
(33 – 40) |
.81 |
Leukocytes, x 109/L |
10.8 |
(7.7 – 14.8) |
10.6 |
(7.0 – 16.2) |
.76 |
Lymphocytes, x 109/L |
1.1 |
(0.8 – 1.7) |
1.0 |
(0.8 – 1.4) |
.49 |
Thrombocytes, x 109/L |
220 |
(177 – 309) |
242 |
(190 – 322) |
.52 |
C-reactive protein, mg/L |
14.3 |
(5.5 – 22.2) |
16.4 |
(6.4 – 31.2) |
.26 |
Ferritin, mcg/L |
1192 |
(679 – 1502) |
1502 |
(704 – 1502) |
.20 |
D-Dimer, mg/L |
225 |
(139 – 668) |
333 |
(124 – 1060) |
.59 |
Fibrinogen, g/L |
5.4 |
(4.4 – 6.5) |
5.7 |
(5.0 – 6.9) |
.12 |
APTT, sec |
36.0 |
(32.9 – 40.8) |
36.2 |
(29.0 – 40.2) |
.47 |
Creatinine, mol/L |
97 |
(70 – 129) |
82 |
(63 – 117) |
.08 |
Aspartate aminotransferase,
U/L |
42 |
(30 – 66) |
50 |
(30 – 69) |
.77 |
Alanine aminotransferase, U/L |
42 |
(25 – 56) |
41 |
(31 – 54) |
.96 |
Lactate dehydrogenase, U/L |
357 |
(260 – 443) |
336 |
(268 – 460) |
.77 |
Creatin Kinase, U/L |
127 |
(64 – 343) |
210 |
123 – 474) |
0.08 |
APTT: Activated Partial Thromboplastin Time.